A Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says
Time
—
Retatrutide, an experimental injectable drug, targets three hormones related to weight loss.
Lilly weight loss drug results
- New Eli Lilly weight loss drug has dramatic effects in clinical trial Washington Examiner —
- Eli Lilly’s next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial The Indian Express —
- Eli Lilly says next-gen obesity drug helps patients lose 28% of body weight - Reuters Reuters —
- New weight-loss shot appears to outperform other obesity drugs on market The Guardian —
- Eli Lilly: Next-gen weight loss drug may be more effective than others UPI —